STXS241220P5000
- 0.00
- 0.000.00%
Stereotaxis Newsroom
STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
Strategic Partnerships and Regulatory Advancements Propel Stereotaxis to Buy Rating
Express News | Stereotaxis Inc: Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
Hospital in Portugal Adopts Stereotaxis Surgical Robot
Stereotaxis Announces That Physicians At The Hospital Da Luz In Lisbon, Portugal Have Successfully Treated The First Patients Using The Advanced Genesis Robotic Magnetic Navigation System
Stereotaxis | 10-Q: Q3 2024 Earnings Report
Piper Sandler Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $4
Stereotaxis | 8-K: Stereotaxis Reports 2024 Third Quarter Financial Results
Piper Sandler Releases a Buy Rating on Stereotaxis (STXS)
Stereotaxis Reports Strong Q3 Growth in Robotics
TD Cowen Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $5
Bullish Outlook on Stereotaxis: Strong Revenue Growth and Promising Pipeline
Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript Summary
Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q3 Loss, Tops Revenue Estimates
Stereotaxis Q3 2024 GAAP EPS $(0.08) Misses $(0.05) Estimate, Sales $9.196M Beat $7.100M Estimate
Stereotaxis Reiterates Expectation for Full Yr Rev to Be Approximately Equal to Previous Yr
Earnings Flash (STXS) STEREOTAXIS Reports Q3 Revenue $9.2M